Atlas Trials

Personalized TCR-T: Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T)

Clinical trial NCT05349890 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05349890
Sponsor
Providence Health & Services
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Malignant Epithelial Neoplasms
Start date
2023-04-03
Primary completion
2027-04-15
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.